KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Accounts Payables (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Accounts Payables readings, the most recent being $2.6 billion for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 13.36% to $2.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.6 billion, a 13.36% increase, with the full-year FY2025 number at $2.5 billion, up 14.89% from a year prior.
  • Accounts Payables hit $2.6 billion in Q1 2026 for Teva Pharmaceutical Industries, up from $2.5 billion in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $2.6 billion in Q4 2023 to a low of $1.6 billion in Q3 2022.
  • Median Accounts Payables over the past 5 years was $2.4 billion (2024), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Accounts Payables: surged 39.45% in 2023 and later dropped 15.33% in 2024.
  • Teva Pharmaceutical Industries' Accounts Payables stood at $1.9 billion in 2022, then skyrocketed by 37.89% to $2.6 billion in 2023, then dropped by 15.33% to $2.2 billion in 2024, then increased by 14.89% to $2.5 billion in 2025, then grew by 2.57% to $2.6 billion in 2026.
  • The last three reported values for Accounts Payables were $2.6 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.4 billion (Q3 2025) per Business Quant data.